Ikarian Capital »

Maze Therapeatics shares owned by Ikarian Capital

Quarter-by-quarter ownership of Maze Therapeatics (MAZE) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Maze Therapeatics

Tip: Access up to 7 years of quarterly data

All positions including Maze Therapeatics held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Maze Therapeatics by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $19M 741k 25.93
2025-06-30 $3.2M 263k 12.27
2025-03-31 $3.6M 323k 11.01

More positions owned by Ikarian Capital

United Therapeutics Corporation Put Option (UTHR)
Spdr Series Trust S&p Biotech Put Option (XBI)
Genmab A/s Sponsored Ads (GMAB)
Bristol Myers Squibb Put Option (BMY)
Abivax Sa Sponsored Ads (ABVX)
Uniqure Nv Call Call Option
Insmed Com Par $.01 (INSM)
Ptc Therapeutics I (PTCT)
Ionis Pharmaceuticals (IONS)
Cidara Therapeutics Com New (CDTX)
Scholar Rock Hldg Corp Put Option (SRRK)
Rapt Therapeutics Com New (RAPT)
Maze Therapeatics (MAZE)
Soleno Therapeutics (SLNO)
Cytokinetics Com New (CYTK)

View all positions for Ikarian Capital

Top funds holding Maze Therapeatics

Trv Gp Iv
Frazier Life Sciences Management
Arch Venture Corp
Deep Track Capital
Alphabet
AH Capital Management
Matrix Capital Management Company
Vanguard Group
BlackRock
VR Adviser
Logos Global Management
General Catalyst Group Management
Woodline Partners
TRV GP V
Marshall Wace

View all funds holding Maze Therapeatics